TP53INP1 and hepatocellular carcinoma: TP53INP1 has been implicated as a tumour suppressor in additional malignancies such as hepatocellular carcinoma (HPCC), breast cancer and pancreatic cancer, possibly providing scope for studying whether and how miR-155-5p/3p promote cancer in these contexts [161–163].